Acorda Therapeutics Relocates Corporate Headquarters To Ardsley Park Life Science Campus

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the official opening of the Company’s new corporate headquarters at the Ardsley Park life science campus in Ardsley, New York. The new facility, which is leased from BioMed Realty Trust, Inc. (NYSE: BMR), includes approximately 138,000 square feet of office and state-of-the-art laboratory space. Acorda has relocated all employees from its former location in Hawthorne, New York to the new Ardsley facility.

“Acorda moved to Westchester in 1998 as a small start-up biotechnology company with six employees, and I’m very proud of what our associates have accomplished in the ensuing years. We’ve brought an important new therapy to market AMPYRA, which has helped tens of thousands of people with multiple sclerosis. That in turn has helped us grow our Company to become a leader in developing neurological medicines, with more than 340 associates, including 200 based in Ardsley,” said Ron Cohen, M.D., Acorda’s President and CEO. “As a native New Yorker, it is also gratifying to contribute to the expanding biotechnology presence in Westchester County. Westchester has the resources we need, in particular a highly educated and skilled workforce, to continue to grow and pursue our goal to develop therapies that improve the lives of people living with MS, stroke, spinal cord injury, and other neurological conditions.”

Acorda’s partnership with Empire State Development Corporation, County of Westchester Industrial Development Agency (IDA), New York State Energy Research and Development Authority (NYSERDA) and the County of Westchester, New York produced an economic incentive package that made the move economically feasible for the Company, while promoting the retention of existing jobs and creation of new jobs in New York. Acorda will receive tax credits of up to $5.2 million as part of the New York State Excelsior Jobs Program, an employment-creation initiative administered by Empire State Development. Acorda is also eligible for various tax credits of up to $1.15 million through the County of Westchester IDA and for additional incentives through NYSERDA.

If you liked this article you might like

Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers

Acorda Stiff-Arms Investor's Demand for Sale

Biotech Movers: Adamis Shares Jump After FDA Approves Epinephrine Pre-filled Syringe